showed that hsa-miR-26b suppresses NF-κB signalling and thereby sensitizes HCC cells to doxorubicin-induced apoptosis by binding the 3′UTR of TAK1 and TAB3 [25]. This evidence concerns the gene TAB3 and hepatocellular carcinoma.